Home    中文  
 
  • Search
  • lucene Search
  • Citation
  • Fig/Tab
  • Adv Search
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited

Chinese Journal of Gastroesophageal Reflux Disease(Electronic Edition) ›› 2023, Vol. 10 ›› Issue (02): 96-99. doi: 10.3877/cma.j.issn.2095-8765.2023.02.007

• Reviews • Previous Articles     Next Articles

Research progress in the treatment of gastroesophageal reflux disease by endoscopic cardiac coarctation

Peng Li, Guoxiang Liu, Ruhong Li()   

  1. Department of General Surgery, Yan’an Hospital Affiliated to Kunming Medical University, Kunming 650051, China
  • Received:2023-01-14 Online:2023-05-15 Published:2023-11-07
  • Contact: Ruhong Li

Abstract:

Peroral endoscopic cardial constriction (PECC) can effectively treat gastroesophageal reflux disease (GERD), reduce the use rate of antiacid drugs, reduce reflux symptoms of patients, and improve the quality of life of patients. However, the therapeutic principle and long-term therapeutic effect of PECC in treating GERD are not completely clear, and many related studies cannot fully unify some indicators of this technology. In this paper, the latest research progress of this technology is reviewed.

Key words: Gastroesophageal reflux disease, Peroral endoscopic cardial constriction, Proton-pump inhibitor, Lower esophageal sphincter

京ICP 备07035254号-20
Copyright © Chinese Journal of Gastroesophageal Reflux Disease(Electronic Edition), All Rights Reserved.
Tel: 0991-8563812 E-mail: zhwsgflbzz@163.com
Powered by Beijing Magtech Co. Ltd